tiprankstipranks
Advertisement
Advertisement

HK:1541 Stock Latest News

ImmuneOnco Dilutes Stake in Subsidiary via De Minimis Connected Capital Injection
Company AnnouncementsImmuneOnco Dilutes Stake in Subsidiary via De Minimis Connected Capital Injection
10d ago
1541
ImmuneOnco Deploys HK$87.5 Million Into Vital Ventures Cash Management Funds
PremiumCompany Announcements
ImmuneOnco Deploys HK$87.5 Million Into Vital Ventures Cash Management Funds
11d ago
1541
ImmuneOnco plans on-market H-share buyback to signal confidence and boost value
PremiumCompany Announcements
ImmuneOnco plans on-market H-share buyback to signal confidence and boost value
20d ago
1541
ImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
PremiumCompany Announcements
ImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
1M ago
1541
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
PremiumCompany Announcements
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
1M ago
1541
ImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
PremiumCompany AnnouncementsImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
1M ago
1541
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
Premium
Company Announcements
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
2M ago
1541
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
Premium
Company Announcements
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
3M ago
1541
ImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
PremiumCompany Announcements
ImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
3M ago
1541
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
PremiumCompany Announcements
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
3M ago
1541
ImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
ImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
4M ago
1541
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
PremiumCompany Announcements
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
4M ago
1541
ImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
PremiumCompany AnnouncementsImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
5M ago
1541
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
Premium
Company Announcements
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
5M ago
1541
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
Premium
Company Announcements
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
6M ago
1541
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
PremiumCompany Announcements
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
6M ago
1541
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
PremiumCompany Announcements
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
7M ago
1541
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
PremiumCompany Announcements
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
7M ago
1541
ImmuneOnco Redeems and Subscribes to Wealth Management Products
PremiumCompany Announcements
ImmuneOnco Redeems and Subscribes to Wealth Management Products
7M ago
1541
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
PremiumCompany AnnouncementsImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
7M ago
1541
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
Premium
Company Announcements
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
8M ago
1541
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
Premium
Company Announcements
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
8M ago
1541

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >